Trials that use: Covariate adjustment
5,848 results
- Lifeflight: Fentanyl Versus Morphine: Complete Statistical AnalysisIndependent statistical analysis of Lifeflight: Fentanyl Versus Morphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580489).
- LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound: Complete Statistical AnalysisIndependent statistical analysis of LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lifestyle Intervention in Preparation for Pregnancy (LIPP): Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Intervention in Preparation for Pregnancy (LIPP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03146156).
- Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne: Complete Statistical AnalysisIndependent statistical analysis of Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne: primary endpoint results, effect estimate with…
- Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03794908).
- Lighting Intervention for Cancer-related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Lighting Intervention for Cancer-related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827446).
- LIMMITLESSIndependent statistical analysis of A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ): primary endpoint results, effect estimate with…
- Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone: Complete Statistical AnalysisIndependent statistical analysis of Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LINK: Aftercare Monitoring Project: Complete Statistical AnalysisIndependent statistical analysis of LINK: Aftercare Monitoring Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00265512).
- Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lipid Metabolism in Gestational Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Lipid Metabolism in Gestational Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00534105).
- Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01315236).
- Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149887).
- Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIPS-A: Lung Injury Prevention Study With Aspirin: Complete Statistical AnalysisIndependent statistical analysis of LIPS-A: Lung Injury Prevention Study With Aspirin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01504867).
- Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients: Complete Statistical AnalysisIndependent statistical analysis of Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: Complete Statistical AnalysisIndependent statistical analysis of Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Litramine in Weight Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Litramine in Weight Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01505387).
- Little Cigar and Cigarillo Warnings for Youth: Complete Statistical AnalysisIndependent statistical analysis of Little Cigar and Cigarillo Warnings for Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06413797).
- Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: Complete Statistical AnalysisIndependent statistical analysis of Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LIVE-PEIndependent statistical analysis of Losartan for Improved Vascular Endothelial Function After Preeclampsia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04632589).
- Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging: Complete Statistical AnalysisIndependent statistical analysis of Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03637959).
- Living Well Project for Persons With AIDS: Complete Statistical AnalysisIndependent statistical analysis of Living Well Project for Persons With AIDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01848483).
- LLTEVARIndependent statistical analysis of LSA Reconstruction With Laser Fenestration During the TEVAR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03845829).
- LLWSIndependent statistical analysis of Live Long Walk Strong (LLWS) Rehabilitation Program: What Features Improve Mobility Skills: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Local Anesthetic as Single Shot Versus Catheter in Patients Undergoing Video Assisted Thoracoscopic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Local Anesthetic as Single Shot Versus Catheter in Patients Undergoing Video Assisted Thoracoscopic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LoGoIndependent statistical analysis of Low-dose Gonal-f® in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01871532).
- LOGRIBMETIndependent statistical analysis of Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes – a Randomized Pragmatic Trial: Complete Statistical AnalysisIndependent statistical analysis of Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial:…
- Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg): Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen…
- Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex: Complete Statistical AnalysisIndependent statistical analysis of Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-term Active Surveillance Study for Oral Contraceptives (LASS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Active Surveillance Study for Oral Contraceptives (LASS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00676065).
- Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563): Complete Statistical AnalysisIndependent statistical analysis of Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome): Complete Statistical AnalysisIndependent statistical analysis of Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Open-Label Safety Study to Evaluate EN3409: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-Label Safety Study to Evaluate EN3409: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755546).
- Long-term Outcomes After Percutaneous Closure of PFO: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcomes After Percutaneous Closure of PFO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05558774).
- Long-Term Retention of Gadolinium in Bone: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Retention of Gadolinium in Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853163).
- Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-Term Study of Nitisinone to Treat Alkaptonuria: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Nitisinone to Treat Alkaptonuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107783).
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Follow-up of High School Athletes: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow-up of High School Athletes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02432183).